935269-27-5 Usage
Uses
Used in Pharmaceutical Industry:
3-OXO-2,3-DIHYDRO-1H-ISOINDOLE-4-CARBOXYLIC ACID is used as a key intermediate for the synthesis of various pharmaceuticals due to its ability to create complex molecules with important biological activities. Its versatile reactivity allows for the development of new drugs with potential therapeutic benefits.
Used in Agrochemical Industry:
3-OXO-2,3-DIHYDRO-1H-ISOINDOLE-4-CARBOXYLIC ACID is also used as a building block in the synthesis of agrochemicals, contributing to the development of effective and innovative products for agricultural applications.
Used in Drug Discovery and Development:
3-OXO-2,3-DIHYDRO-1H-ISOINDOLE-4-CARBOXYLIC ACID is utilized as a crucial component in drug discovery and development processes. Its potential applications in creating molecules with significant biological activities make it an important compound in the advancement of new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 935269-27-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,5,2,6 and 9 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 935269-27:
(8*9)+(7*3)+(6*5)+(5*2)+(4*6)+(3*9)+(2*2)+(1*7)=195
195 % 10 = 5
So 935269-27-5 is a valid CAS Registry Number.
935269-27-5Relevant articles and documents
7-[1H-Indol-2-yl]-2,3-dihydro-isoindol-1-ones as dual Aurora-A/VEGF-R2 kinase inhibitors: Design, synthesis, and biological activity
Hughes, Terry V.,Emanuel, Stuart L.,O'Grady, Harold R.,Connolly, Peter J.,Rugg, Catherine,Fuentes-Pesquera, Angel R.,Karnachi, Prabha,Alexander, Richard,Middleton, Steven A.
scheme or table, p. 5130 - 5133 (2009/05/26)
A novel series of 7-[1H-indol-2-yl]-2,3-dihydro-isoindol-1-ones designed to be inhibitors of VEGF-R2 kinase was synthesized and found to potently inhibit VEGF-R2 and Aurora-A kinases. The structure-based design, synthesis, and initial SAR of the series are discussed.
SUBSTITUTED DIHYDRO-ISOINDOLONES USEFUL IN TREATING KINASE DISORDERS
-
Page/Page column 69, (2008/06/13)
The present invention is directed to novel substituted dihydro-isoindolone compounds of formula (I): and forms thereof, wherein Ring A, X3, R1, R2, R3, R4 and R6 are as herein defined, and their synthesis and use as protein kinase inhibitors and interactions thereof.
